Swiss pharmaceutical company Novartis has filed a lawsuit against President Joe Biden's administration over a disagreement regarding the 340B Drug Discount Program. The company claims that the U.S. Health Resources and Services Administration interpreted a federal law wrongly, preventing Novartis from changing payment terms for participating hospitals. This move by Novartis could have significant repercussions on the negotiation process for the company's popular heart drug, Entresto, and its pricing under Medicare. Stay updated on market-moving news with TheFly and check out top-performing stocks on TipRanks.
Novartis Sues Biden Administration Over 340B Drug Discount Program
Swiss pharmaceutical giant Novartis has filed a lawsuit against the Biden administration over a disagreement regarding the 340B Drug Discount Program. The company claims that the U.S. Health Resources and Services Administration (HRSA) interpreted a federal law wrongly, preventing Novartis from changing payment terms for participating hospitals.
The 340B Drug Discount Program is a federal program that was established in 1992 to provide discounted prescription drugs to low-income and uninsured patients. Hospitals that participate in the program are required to pass along the discounts they receive from drug manufacturers to patients.
Novartis argues that the HRSA has misinterpreted the 340B law by requiring drug manufacturers to provide discounts to hospitals regardless of whether the drugs are actually used to treat low-income or uninsured patients. The company says that this interpretation of the law has led to "significant overpayments" to hospitals and that it has been forced to subsidize the program with its own profits.
The lawsuit could have significant repercussions on the negotiation process for Novartis's popular heart drug, Entresto. The drug is currently covered under Medicare Part D, and Novartis is seeking to change the payment terms for Entresto in order to increase its profits. The lawsuit could delay or prevent Novartis from making these changes, which could impact the price of Entresto for Medicare beneficiaries.
Background
The 340B Drug Discount Program was created as part of the Omnibus Budget Reconciliation Act of 1990. The program was originally designed to help hospitals that serve a disproportionate share of low-income and uninsured patients. The program has since been expanded to include a wider range of hospitals, including many that do not serve a disproportionate share of low-income and uninsured patients.
In 2010, the Affordable Care Act made significant changes to the 340B program. The changes included adding new eligibility requirements for hospitals and increasing the discounts that drug manufacturers are required to provide.
Top 5 FAQs
1. What is the 340B Drug Discount Program?
The 340B Drug Discount Program is a federal program that requires drug manufacturers to provide discounts to hospitals that serve a disproportionate share of low-income and uninsured patients. The program is designed to help these hospitals provide affordable prescription drugs to their patients.
2. What is Novartis's lawsuit about?
Novartis is suing the Biden administration over the HRSA's interpretation of the 340B law. Novartis argues that the HRSA is requiring drug manufacturers to provide discounts to hospitals regardless of whether the drugs are actually used to treat low-income or uninsured patients.
3. What could the lawsuit mean for Novartis?
The lawsuit could delay or prevent Novartis from making changes to the payment terms for its popular heart drug, Entresto. This could impact the price of Entresto for Medicare beneficiaries.
4. What could the lawsuit mean for the 340B program?
The lawsuit could have a significant impact on the 340B program. If Novartis is successful in its lawsuit, it could lead to changes in the way that the program is administered. This could make it more difficult for hospitals to participate in the program or could reduce the discounts that hospitals receive from drug manufacturers.
5. What is the future of the 340B program?
The future of the 340B program is uncertain. The program has been the subject of ongoing debate, with some stakeholders arguing that it is too costly and that it does not effectively target low-income and uninsured patients. However, the program remains popular with hospitals and patient advocates, and it is likely to continue to be a source of controversy in the years to come.
The First Lady has caused a stir in the cryptocurrency world with the release of her own memecoin, $MELANIA, which surpassed the value of her husband's Trump Coin by an astounding 8,694.61%. The launch comes just days after Trump Coin's initial surge, which has now been overshadowed by $MELANIA's meteoric rise. This move further solidifies the couple's influence beyond the political realm, as they capitalize on the booming crypto market.
As President Donald Trump's newly launched $TRUMP memecoin continues to gain attention in the cryptocurrency world, his wife Melania Trump has followed suit by launching her own token, $MELANIA. Valued at a reported several billion dollars, $MELANIA differs in structure from $TRUMP and has already seen a surge in market price and volume. While $TRUMP has also seen success, achieving a market cap of $9.9 billion, $MELANIA's launch has added another fascinating element to the Trump cryptocurrency saga.
Phoenix Supported Housing CIC, along with former and current directors Kimberley Bethell and Davinder Singh Chall, were prosecuted by a council after allegedly failing to provide promised support to a vulnerable tenant. The tenant fell into debt and was illegally evicted due to the company's actions. Bethell and Chall were each sentenced to suspended prison time and ordered to pay the tenant £1,500 each. The company was fined and ordered to pay legal costs. The judge described the defendants' behavior as "thoroughly wicked" and they were urged to be ashamed of themselves.
After facing a series of issues on a recent bus trip with VRL Travels, BHPian ghodlur shares the details with other automotive enthusiasts. From delays to unmaintained buses, the experience raises questions about the cost of prioritizing price over quality. With a return trip planned, the BHPian turns to social media for advice on whether to stick with this budget option or opt for a carpooling app instead. Indian car enthusiasts discuss their experiences and suggest ways to stay updated on the automotive scene.
The popular social media app, TikTok, was set to be banned in the US due to national security concerns, impacting 170 million American users and over 7 million small businesses. However, President-elect Donald Trump has announced that he will work with the app's parent company ByteDance to protect national security and allow for a 50% ownership by American companies. This unexpected turn of events has relieved many TikTok users and avoided a potential strain on US-China relations.
In just 18 months, 26-year-old Jeet Shah, a LD Engineering College graduate, amassed a fortune through his digital marketing training business and YouTube channel. After initially balancing his studies with food delivery gigs, the pandemic forced him to pivot to digital marketing, which he excelled at. Now, he uses his expertise to empower individuals and businesses while also inspiring others through his journey.
The stock market can be intimidating for investors of any age and experience, but finding winning stocks can be made easier with the help of Zacks Style Scores. For growth-oriented investors, Amphenol (APH) is a promising choice with a solid Zacks Rank, Growth Style Score of B, and VGM Score of B. With expected increases in earnings and sales, as well as strong cash flow growth, APH should be on the radar for investors looking for sustainable growth in the long term.
Greaves Cotton Limited, a renowned engineering company, stole the spotlight at Auto Expo 2025 with their new and innovative mobility solutions. These solutions, which align with the company's transition to a multi-business enterprise, include electric two- and three-wheelers, advanced charging solutions, and upgraded vehicle models. With notable products like the 'Made in India' e-motorcycle 'Xyber' and a commitment to sustainable mobility, Greaves Cotton Limited aims to make a positive impact on the environment and the lives of consumers.
Following the recent removal of Tik Tok from the US Apple store and the threat of an impending ban, US-based search engine, Perplexity, has submitted a bid to purchase the popular video app. This could be a potential lifeline for Tik Tok as they face pressure from the US government to cut ties with parent company ByteDance. The merger could bring together two vastly different applications, with Perplexity known for its language models and ability to gather information from open-source AI platforms. This unexpected turn of events could potentially pave the way for a new chapter in Tik Tok's future.